 The Hindu | Dr. Reddy's Lab third quarter net jumps to Rs.513 crore The Hindu The growth was led by the high value launch of Olanzapine 20 mg which alone accounted for revenue of $99 million, new products launched in the last 12 months and strong volume growth generated by key products such as lansoprazole, tacrolimus and ... Dr Reddy's posts 88% jump in Q3 net profit to Rs 513 cr Net soars 88% at Rs 512 crore Dr Reddy's profit rises 88% on schizophrenia drug sales |
